Literature DB >> 30101363

Application of decellularized allograft for primary repair of congenital heart disease in Japan.

Hideto Ozawa1, Takayoshi Ueno1, Masaki Taira1, Koichi Toda1, Toru Kuratani1, Yoshiki Sawa2.   

Abstract

A 6-month-old infant with a double outlet right ventricle, doubly committed ventricular septal defect, and right ventricle outflow tract (RVOT) stenosis underwent intracardiac repair with RVOT reconstruction using a fresh decellularized allograft derived from a 1-year-old heart transplant recipient in Japan. Early postoperative evaluation via echocardiography and cardiac magnetic resonance imaging revealed that the pulmonary allograft and cardiac function were stable. This is the first case report on using a decellularized heart valve, which was resected from a heart transplant recipient, for primary repair of congenital heart disease in Japan.

Entities:  

Keywords:  Congenital heart disease; Decellularization; Tissue engineering

Year:  2018        PMID： 30101363     DOI： 10.1007/s11748-018-0988-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  6 in total

1.  Ice-free cryopreservation of heart valve allografts: better extracellular matrix preservation in vivo and preclinical results.

Authors:  Kelvin G M Brockbank; Katja Schenke-Layland; Elizabeth D Greene; Zhenzhen Chen; Olaf Fritze; Martina Schleicher; Renate Kaulitz; Iris Riemann; Falko Fend; Johannes M Albes; Ulrich A Stock; Milan Lisy
Journal:  Cell Tissue Bank       Date:  2012-01-03       Impact factor: 1.522

2.  Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report.

Authors:  Serghei Cebotari; Igor Tudorache; Anatol Ciubotaru; Dietmar Boethig; Samir Sarikouch; Adelheid Goerler; Artur Lichtenberg; Eduard Cheptanaru; Sergiu Barnaciuc; Anatol Cazacu; Oxana Maliga; Oleg Repin; Liviu Maniuc; Thomas Breymann; Axel Haverich
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

3.  European homograft bank: twenty years of cardiovascular tissue banking and collaboration with transplant coordination in Europe.

Authors:  R Jashari; Y Goffin; A Vanderkelen; B Van Hoeck; A du Verger; Y Fan; V Holovska; O Brahy
Journal:  Transplant Proc       Date:  2010 Jan-Feb       Impact factor: 1.066

4.  Early systemic cellular immune response in children and young adults receiving decellularized fresh allografts for pulmonary valve replacement.

Authors:  Anneke Neumann; Samir Sarikouch; Thomas Breymann; Serghei Cebotari; Dietmar Boethig; Alexander Horke; Philipp Beerbaum; Mechthild Westhoff-Bleck; Harald Bertram; Masamichi Ono; Igor Tudorache; Axel Haverich; Gernot Beutel
Journal:  Tissue Eng Part A       Date:  2014-01-24       Impact factor: 3.845

5.  Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience.

Authors:  Samir Sarikouch; Alexander Horke; Igor Tudorache; Philipp Beerbaum; Mechthild Westhoff-Bleck; Dietmar Boethig; Oleg Repin; Liviu Maniuc; Anatol Ciubotaru; Axel Haverich; Serghei Cebotari
Journal:  Eur J Cardiothorac Surg       Date:  2016-03-24       Impact factor: 4.191

6.  Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation.

Authors:  Laura Iop; Antonella Bonetti; Filippo Naso; Stefania Rizzo; Stefano Cagnin; Roberto Bianco; Carlo Dal Lin; Paolo Martini; Helen Poser; Paolo Franci; Gerolamo Lanfranchi; Roberto Busetto; Michel Spina; Cristina Basso; Maurizio Marchini; Alessandro Gandaglia; Fulvia Ortolani; Gino Gerosa
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.